SentreHEART Secures $35,000,000 Series D Funding Round

  • Feed Type
  • Date
    9/29/2016
  • Company Name
    SentreHEART
  • Mailing Address
    300 Saginaw Drive Redwood City, CA 94063 USA
  • Company Description
    SentreHEART, Inc. is developing minimally invasive devices to protect and treat disorders of the heart.
  • Website
    http://www.sentreheart.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $35,000,000
  • Transaction Round
    Series D
  • Proceeds Purposes
    The proceeds will be utilized to complete the aMAZE (alternative-MAZE) randomized, pivotal clinical trial evaluating the use of the LARIAT device for closure of the LAA as an adjunctive treatment to ablation in patients with persistent or longstanding persistent atrial fibrillation (AFib).
  • M&A Terms
  • Venture Investor
    Deerfield Capital
  • Venture Investor
    U.S. Venture Partners
  • Venture Investor
    Prospect Venture Partners
  • Venture Investor
    Vivo Capital
  • Venture Investor
    Decheng Capital

Trending on Xconomy